Unlearn, a startup creating digital twins used in the control arm of clinical trials, announced today an extension to its Series A funding round, bringing the total amount raised to $15 million.
New investors Eisai, Epic Ventures and Alumni Ventures Group contributed to the oversubscribed round. They join 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures, which contributed to Unlearn’s original...
